Loading patent…
AssigneesNational Institute for Materials Science, Furuuchi Chemical Corporation
InventorsTetsushi Taguchi, Hisatoshi Kobayashi, Junzo Tanaka, Hirofumi Saito
Estimating the term…
The crosslinking agents and condensing agents that have been employed in biological adhesives and in treating medical devices such as cardiac valves are non-natural compounds synthesized artificially. Thus, they are not metabolized in vivo and exhibit toxicity to living bodies. These compounds are thus used only in a restricted amount and for limited purposes in the clinical sites. The present invention provides a biological low-molecular-weight derivative obtained by modifying carboxyl groups of a biological low-molecular-weight compound with N-hydroxysuccinimide, N-hydroxysulfosuccinimide, or a derivative thereof and a crosslinked high-molecular-weight product obtained by crosslinking various high-molecular-weight compounds with this derivative.
A crosslinked high-molecular-weight product obtained by crosslinking a high-molecular-weight compound with a biological low-molecular-weight compound, the crosslinked high-molecular-weight product comprising a gel that is metabolized in vivo after application in vivo,
A method for producing a crosslinked high-molecular-weight product comprising:
Dependencies are inferred from the claim text.